Carbapenem-Resistant NDM and OXA-48-
Carbapenem-resistant Klebsiella pneumoniae
ESKAPE pathogens
NDM+OXA-48-like
antibiotic therapies
carbapenemases
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
12 May 2024
12 May 2024
Historique:
received:
08
03
2024
revised:
21
04
2024
accepted:
09
05
2024
medline:
24
5
2024
pubmed:
24
5
2024
entrez:
24
5
2024
Statut:
epublish
Résumé
Carbapenem-resistant A retrospective observational cohort study including all hospitalized patients with Cr-Kpn isolates. We reported data as percentages and identified independent predictors for mortality over hospital time through multivariate analysis. The main type of carbapenemases identified were NDM+OXA-48- The increase in the incidence of Cr-Kpn infections, especially with NDM+OXA-48-
Sections du résumé
BACKGROUND
BACKGROUND
Carbapenem-resistant
METHODS
METHODS
A retrospective observational cohort study including all hospitalized patients with Cr-Kpn isolates. We reported data as percentages and identified independent predictors for mortality over hospital time through multivariate analysis.
RESULTS
RESULTS
The main type of carbapenemases identified were NDM+OXA-48-
CONCLUSIONS
CONCLUSIONS
The increase in the incidence of Cr-Kpn infections, especially with NDM+OXA-48-
Identifiants
pubmed: 38786163
pii: antibiotics13050435
doi: 10.3390/antibiotics13050435
pii:
doi:
Types de publication
Journal Article
Langues
eng